Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed 2021-10-01 Acc 0001209191-21-058527

Director bought 882 shares at an average $2.83 ($2,495)

From the SEC's structured data for this filing

Trades in this filing

Insider	Date	Transaction	Shares	Price	Value	Owned after	D/I
Jones James Director	2021-09-01	Purchase	+42	$2.88	$121	16,338	D
Jones James Director	2021-09-02	Purchase	+42	$2.88	$121	16,380	D
Jones James Director	2021-09-03	Purchase	+42	$2.85	$120	16,422	D
Jones James Director	2021-09-07	Purchase	+42	$2.79	$117	16,464	D
Jones James Director	2021-09-08	Purchase	+42	$2.89	$121	16,506	D
Jones James Director	2021-09-09	Purchase	+42	$2.77	$116	16,548	D
Jones James Director	2021-09-10	Purchase	+42	$2.78	$117	16,590	D
Jones James Director	2021-09-13	Purchase	+42	$2.96	$124	16,632	D
Jones James Director	2021-09-14	Purchase	+42	$3.02	$127	16,674	D
Jones James Director	2021-09-15	Purchase	+42	$2.86	$120	16,716	D
Jones James Director	2021-09-16	Purchase	+42	$2.91	$122	16,758	D
Jones James Director	2021-09-17	Purchase	+42	$2.85	$120	16,800	D
Jones James Director	2021-09-20	Purchase	+42	$2.82	$118	16,842	D
Jones James Director	2021-09-21	Purchase	+42	$2.81	$118	16,884	D
Jones James Director	2021-09-22	Purchase	+42	$2.76	$116	16,926	D
Jones James Director	2021-09-23	Purchase	+42	$2.75	$116	16,968	D
Jones James Director	2021-09-24	Purchase	+42	$2.74	$115	17,010	D
Jones James Director	2021-09-27	Purchase	+42	$2.79	$117	17,052	D
Jones James Director	2021-09-28	Purchase	+42	$2.76	$116	17,094	D
Jones James Director	2021-09-29	Purchase	+42	$2.82	$118	17,136	D
Jones James Director	2021-09-30	Purchase	+42	$2.72	$114	17,178	D
Open-market purchases · 882 sh · avg $2.83 · $2,495